The minimum concentration of a drug in the body after dosing.
Glossary
Cmin
02.27.12
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
LSNE, Selecta Biosciences Form Mfg. Pact
LSNE to provide drug substance manufacturing and fill/finish services
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Selexis SA and OSE Immunotherapeutics Enter Pact
Sign agreement for the development of OSE's interleukin receptor 7 antagonist
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News | Preclinical Outsourcing | R&D
Nektar and Takeda in Research Collaboration
Will explore combination cancer therapies
-
Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
Novartis in $225M Cardiovascular Deal With Ionis
Goal is to develop and commercialize AKCEA-APO(a)-L Rx and AKCEA-APOCIII-L Rx
-
Drug Development | Industry News
IMAB Licenses Phase II Ferring Compound
Olamkicept is under development to treat autoimmune disease
